AstraZeneca Imfinzi plus chemotherapy recommended for marketing authorisation in EU for advanced biliary tract cancer Ruchika Sharma15 Nov 2022 5:44 PM ISTUK: AstraZeneca's Imfinzi (durvalumab) has been recommended for marketing authorisation in the European Union (EU) for the 1st-line treatment of adult...
High levels of popular supplement could increase risk of developing breast cancer Dr. Kamal Kant Kohli15 Nov 2022 12:00 PM ISTSwitzerland: Studies in the past have linked commercial dietary supplements like nicotinamide riboside (NR), a form of vitamin B3, to benefits related...
Treatment without hormone blockers improves outcomes in solitary prostate cancer metastases Isra Zaman12 Nov 2022 9:30 AM ISTMetastasis-directed treatment has emerged as a potential alternative for men with "oligorecurrent" prostate cancer - a state of disease with a...
AstraZeneca gets USFDA nod for Imfinzi, Imjudo with chemotherapy to treat metastatic non-small cell lung cancer Ruchika Sharma11 Nov 2022 2:30 PM ISTImfinzi (durvalumab) is a human monoclonal antibody that binds to the PD-L1 protein and blocks the interaction of PD-L1 with the PD-1 and CD80...
Targeted lung cancer drug repotrectinib shows promise in TRIDENT-1 trial Dr. Kamal Kant Kohli29 Oct 2022 4:45 AM ISTResearchers have found in TRIDENT-1 trial that targeted drug repotrectinib could help treat patients with a certain type of non-small cell lung...
Early-stage breast cancer patients who respond favorably to chemotherapy may not need surgery: Lancet Dr. Kamal Kant Kohli26 Oct 2022 8:00 PM ISTResearchers at University of Texas MD Anderson Cancer Center have found in a new study that patients with early-stage breast cancer who had a...
Medical Bulletin 19/October/2022 Isra Zaman19 Oct 2022 5:00 PM ISTHere are the top medical news for the day:Cardiorespiratory fitness is improved by exercise, during and after chemotherapy Cardiorespiratory...
Cardiorespiratory fitness is improved by exercise, during and after chemotherapy Isra Zaman19 Oct 2022 9:00 AM ISTCardiorespiratory fitness, measured by peak oxygen uptake (VO2peak), is regarded as one of the most significant independent predictors of...
Novartis gets positive EMA panel opinion for prostate cancer drug Pluvicto Ruchika Sharma17 Oct 2022 11:32 AM ISTPluvicto is a radioligand therapy combining a targeting compound (ligand, in this case directed to PSMA) with a therapeutic radioisotope
Phase II trial of Jemperli (dostarlimab) plus chemotherapy in patients with metastatic non-squamous non-small cell lung cancer shows positive headline results: GSK Ruchika Sharma9 Oct 2022 2:00 PM ISTJemperli is a programmed death receptor-1 (PD-1)-blocking antibody that binds to the PD-1 receptor and blocks its interaction with the PD-1 ligands...
Serplulimab plus chemotherapy improves survival in Extensive-Stage Small Cell Lung Cancer: JAMA Dr. Shravani Dali6 Oct 2022 8:15 PM ISTIn patients with extensive-stage small cell lung cancer, serplulimab plus chemotherapy as the first-line treatment resulted in improved overall...
NCDRC exonerates 2 Apollo Hospital doctors from medical negligence charges Roshni Dhar26 Sept 2022 5:48 PM ISTThe National Consumer Disputes Redressal Commission recently exonerated two doctors of Apollo Hospital, Kolkata from charges of medical negligence...
